NEWS AND RESOURCES

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.

GemPharmatech LLC., a leading contract research organization, announced today that its Board of Directors has appointed Dr. Brandy Wilkinson as the Chief Executive Officer of its subsidiary in the United States, effective September 12, 2023.

GemPharmatech Launches New Site and Research Platform in Shanghai Baoshan Base

GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange

Recent Publication in Mammalian Genomics

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

LJI and Charles River Laboratories to Collaborate on COVID-19 Research

GemPharmatech US Launches New Website

GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference